FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2583752009> ?p ?o ?g. }

• W2583752009 abstract "Abstract Seventy-one patients with acute myeloid leukemia (AML), most of them (63/71) considered ineligible for conventional allogeneic hematopoietic stem cell transplantation (HSCT), were enrolled into a phase II study on reduced intensity myeloablative conditioning with fractionated 8 Gy total body irradiation (TBI) and fludarabine (120 mg/m2) (Blood. 2005 Nov 1;106(9):3314–21). Patients received mobilized peripheral blood stem cells (n=68) or bone marrow (n=3) from siblings (n=39) or unrelated donors (n=32). HLA-typing was performed for HLA-A, -B, -Cw (serological matching or intermediate resolution DNA typing), DRB1 and DQB1 (high resolution DNA typing). Three patients had unrelated donors with an allele mismatch in HLA DRB1 (2 with an additional mismatch in HLA Cw) and 7 patients were transplanted from unrelated donors with an antigen mismatch in HLA Cw. Thirty-six patients were transplanted in complete remission (CR) and 35 with untreated or refractory disease (non-CR). Median patient age was 51 years (range, 20–66). Sustained engraftment was attained in all evaluable patients. With a median follow-up of now 41.3 months (range, 20.4–70.4) in surviving patients, probabilities of overall survival for patients transplanted in CR and non-CR were 80% (95% CI, 66 to 94%) and 17% (95% CI, 5 – 29%) at 4 years, respectively. Relapse-free survival rates were 57% (95% CI, 39 – 75%) and 14% (95% CI, 2 – 26%). Of the 35 evaluable patients transplanted in CR, 10 patients suffered a relapse between days 68 and 868 after transplantation (cumulative incidence 29%). Five patients with late relapse (>1 year after transplantation) achieved a subsequent CR after conventional chemotherapy, blood stem cell boost and treatment with granulocyte-macrophage colony-stimulating factor, lasting 2000+, 1841+, 909+, 847+ and 480 days, respectively. Depending on donor type, relapse-free survival was similar in patients transplanted from unrelated or sibling donors. Overall survival in patients transplanted in complete remission from unrelated vs. sibling donors was 84% (95% CI, 73 – 95%) vs. 77% (95% CI, 68 – 86%). The cumulative incidence of non-relapse mortality (NRM) in CR patients was 11% at 4 years and beyond (3 patients deceased before day 100 and 1 patient 25 months after transplantation), but amounted to 37% at 4 years in non-CR patients. Nine of the 33 surviving patients (27%) have actually active chronic GvHD (5 limited and 4 extensive disease). This update confirms that allogeneic HSCT from related or unrelated donors with 8 Gy TBI/fludarabine conditioning is feasible with low NRM and preserved long-term antileukemic activity in AML patients in first or later CR." @default.
• W2583752009 created "2017-02-10" @default.
• W2583752009 creator A5004265161 @default.
• W2583752009 creator A5006288618 @default.
• W2583752009 creator A5009160424 @default.
• W2583752009 creator A5013261865 @default.
• W2583752009 creator A5014917310 @default.
• W2583752009 creator A5017002895 @default.
• W2583752009 creator A5025105470 @default.
• W2583752009 creator A5042854645 @default.
• W2583752009 creator A5045626783 @default.
• W2583752009 creator A5045850647 @default.
• W2583752009 creator A5071091625 @default.
• W2583752009 creator A5071987442 @default.
• W2583752009 creator A5074715620 @default.
• W2583752009 creator A5087227508 @default.
• W2583752009 creator A5090092193 @default.
• W2583752009 date "2006-11-16" @default.
• W2583752009 modified "2023-09-27" @default.
• W2583752009 title "Conditioning with 8 Gy Total Body Irradiation and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: Projected 4-Year Update." @default.
• W2583752009 doi "https://doi.org/10.1182/blood.v108.11.3016.3016" @default.
• W2583752009 hasPublicationYear "2006" @default.
• W2583752009 type Work @default.
• W2583752009 sameAs 2583752009 @default.
• W2583752009 citedByCount "0" @default.
• W2583752009 crossrefType "journal-article" @default.
• W2583752009 hasAuthorship W2583752009A5004265161 @default.
• W2583752009 hasAuthorship W2583752009A5006288618 @default.
• W2583752009 hasAuthorship W2583752009A5009160424 @default.
• W2583752009 hasAuthorship W2583752009A5013261865 @default.
• W2583752009 hasAuthorship W2583752009A5014917310 @default.
• W2583752009 hasAuthorship W2583752009A5017002895 @default.
• W2583752009 hasAuthorship W2583752009A5025105470 @default.
• W2583752009 hasAuthorship W2583752009A5042854645 @default.
• W2583752009 hasAuthorship W2583752009A5045626783 @default.
• W2583752009 hasAuthorship W2583752009A5045850647 @default.
• W2583752009 hasAuthorship W2583752009A5071091625 @default.
• W2583752009 hasAuthorship W2583752009A5071987442 @default.
• W2583752009 hasAuthorship W2583752009A5074715620 @default.
• W2583752009 hasAuthorship W2583752009A5087227508 @default.
• W2583752009 hasAuthorship W2583752009A5090092193 @default.
• W2583752009 hasConcept C126322002 @default.
• W2583752009 hasConcept C141071460 @default.
• W2583752009 hasConcept C203014093 @default.
• W2583752009 hasConcept C2776694085 @default.
• W2583752009 hasConcept C2776755627 @default.
• W2583752009 hasConcept C2777408962 @default.
• W2583752009 hasConcept C2778461978 @default.
• W2583752009 hasConcept C2778729363 @default.
• W2583752009 hasConcept C2778880498 @default.
• W2583752009 hasConcept C2779263901 @default.
• W2583752009 hasConcept C2780007613 @default.
• W2583752009 hasConcept C2911091166 @default.
• W2583752009 hasConcept C71924100 @default.
• W2583752009 hasConcept C88879693 @default.
• W2583752009 hasConcept C90924648 @default.
• W2583752009 hasConceptScore W2583752009C126322002 @default.
• W2583752009 hasConceptScore W2583752009C141071460 @default.
• W2583752009 hasConceptScore W2583752009C203014093 @default.
• W2583752009 hasConceptScore W2583752009C2776694085 @default.
• W2583752009 hasConceptScore W2583752009C2776755627 @default.
• W2583752009 hasConceptScore W2583752009C2777408962 @default.
• W2583752009 hasConceptScore W2583752009C2778461978 @default.
• W2583752009 hasConceptScore W2583752009C2778729363 @default.
• W2583752009 hasConceptScore W2583752009C2778880498 @default.
• W2583752009 hasConceptScore W2583752009C2779263901 @default.
• W2583752009 hasConceptScore W2583752009C2780007613 @default.
• W2583752009 hasConceptScore W2583752009C2911091166 @default.
• W2583752009 hasConceptScore W2583752009C71924100 @default.
• W2583752009 hasConceptScore W2583752009C88879693 @default.
• W2583752009 hasConceptScore W2583752009C90924648 @default.
• W2583752009 hasLocation W25837520091 @default.
• W2583752009 hasOpenAccess W2583752009 @default.
• W2583752009 hasPrimaryLocation W25837520091 @default.
• W2583752009 hasRelatedWork W1977112375 @default.
• W2583752009 hasRelatedWork W2077290361 @default.
• W2583752009 hasRelatedWork W2077564760 @default.
• W2583752009 hasRelatedWork W2130040182 @default.
• W2583752009 hasRelatedWork W2346886569 @default.
• W2583752009 hasRelatedWork W2357142827 @default.
• W2583752009 hasRelatedWork W2981871996 @default.
• W2583752009 hasRelatedWork W3003271891 @default.
• W2583752009 hasRelatedWork W3213199609 @default.
• W2583752009 hasRelatedWork W4200132190 @default.
• W2583752009 isParatext "false" @default.
• W2583752009 isRetracted "false" @default.
• W2583752009 magId "2583752009" @default.
• W2583752009 workType "article" @default.